Autres langues Eton Pharmaceuticals, Inc.

Actions

ETON

US29772L1089

Temps Différé Nasdaq Autres places de cotation 19:10:22 06/06/2024			Varia. 5j.	Varia. 1 janv.
3,59 ^USD	-1,37 %		-0,83 %	-18,04 %

09/05	Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
09/05	Eton Pharmaceuticals, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, vs. Street Est of $8M	09/05
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results	09/05
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference	01/05
Sector Update: Health Care Stocks Gain in Afternoon Trading	30/04
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400	30/04
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30/04
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30/04
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	30/04
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	29/04
Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024	17/04
Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding	15/04
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	25/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03
Sector Update: Health Care	22/03
Eton Pharmaceuticals Acquires U.S. Rights to PKU GOLIKE from Relief Therapeutics Holding SA	22/03
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	22/03
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	22/03
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Eton Pharmaceuticals, Inc.

Actions

ETON

US29772L1089

Autres langues

Filtres